Our study suggests that blockade of IL-15 might provide an attractive treatment as an alternative to TNF blockade in RA, able to function both in patients with low baseline synovial expression of TNF and in patients with an unsatisfactory response to TNF blockade. This evidence concerns the gene TNF and rheumatoid arthritis.